CNE100001QV5
CNE100001QV5
LIVZON PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 19.68B EUR | 21.2B EUR | 24.35B EUR |
Enterprise Value | 16.06B EUR | 17.22B EUR | 18.43B EUR |
Valuation Multiples | |||
Trailing P/E | 10.5x | 11.49x | 11.45x |
Forward P/E | 8.36x | -- | -- |
Price to Sales | 1.83x | 1.93x | 2.02x |
Price to Book | 1.26x | 1.59x | 1.68x |
EV/Revenue | 1.49x | 1.57x | 1.53x |
EV/EBITDA | 5.71x | 6.37x | 5.74x |
Price to FCF (P/FCF) | 9.34x | 7.54x | 9.48x |
EV/FCF | 7.62x | 6.12x | 7.17x |
FCF Yield | 10.71% | 13.27% | 10.55% |